Chief Executive Officer
Prior to joining IOTA NanoSolutions Limited, Andrew was the Global Business Director at Oxonica PLC, a world leading Nanotechnology Company. He has previously held senior positions at Ernst and Young LLP in London, and in international business management within the Specialty Chemicals sector, in both the UK and Switzerland. Andrew began his career as a graduate trainee with ICI, and over a period of 18 years gained significant experience of the chemicals sector, holding senior roles in the International Sales, Business Unit Management, Marketing and Sales Purchasing divisions. Andrew has an MBA from Birmingham Business School and a BSc (Hons) degree in Biology from the University of Nottingham. He also has a Graduate Diploma in Marketing (MCIM) from Manchester Business School/Chartered Institute of Marketing.
Commercial Director
Peter joined IOTA NanoSolutions in December 2008 as Commercial Director. As well as managing the financial operation of IOTA NanoSolutions, Peter is responsible for business development in the biocides, agrochemicals and specialty applications sectors. Peter has a broad range of sector experience (FMCG - Paterson Zochonis, Specialty Chemicals - Zeneca/Avecia and Pharma/Biotech - Ipsen) in junior and senior/board positions establishing and restructuring finance operations, managing companies with significant development activities and acquisitions and divestments. He gained his M.Eng in Chemical Engineering from Imperial College in 1987 and ACA while training with Ernst & Young (owner managed/small business department) in 1990. Peter also holds qualifications in marketing (Diploma - CIM), treasury (ACT - Association of Corporate Treasurers) and company direction (Diploma – IoD).
Technical Programme Director
Prior to joining IOTA NanoSolutions, Dave was a Scientist in Unilever's Oral Care Group which he joined in 2001. In 2003, he moved to the Physical Sciences Group where he focused on the development of the IOTA NanoSolutions technology internally within Unilever. Previously, Dave worked at Zeneca in Blackley for 4 years where he was the Leader of the Complex Analysis Team within Zeneca Specialties Business Groups. Here he worked across a number of different areas and sectors including biocides, polymers, polymer additives, dyes, inkjets, pigments, pharmaceuticals and agrochemicals. Dave obtained his first degree in Chemistry and his D.Phil in Low Valent Lanthanide Complexes from the University of Sussex. He also gained considerable post doctoral experience at the University of Warwick where he pioneered the development of ATRP controlled polymerisation with Prof. Dave Haddleton. Dave also worked for a period of time at the Ministry of Defence as an analyst. He is co-author of 30 papers and is co-inventor on 10 published patents.
Laboratory Director
Alison was involved in the original Unilever/Liverpool collaboration that led to the formation of IOTA NanoSolutions Limited, developing the technology for use within the Unilever HPC Business. Prior to working on the IOTA NanoSolutions technology, Alison worked on numerous projects as part of the Molecular Science Unit and later the Physical Sciences Group which included polymer chemistry, synthetic organic chemistry, mechanistic, HTE, sensory molecules and colloid chemistry. Before joining Unilever in 1998, Alison gained post doctoral medicinal chemistry experience at the University of Manchester, School of Pharmacy and Pharmaceutical Sciences, working predominantly with anti-cancer drugs. She gained her BSc in Chemistry (1994) and Ph.D. (1997) from the University of Birmingham in the area of fluorinated dyes as part of a joint collaboration with Courtaulds. Alison has also held positions at Rhodia, working on phosphorus flame-retardants, and at the University of Birmingham working on chiral ligands. She is co-author on 4 papers and 10 published patents and has been awarded a number of prizes including two university scholarships and the Bader Prize in Fluorine Chemistry.
Business Development Director
Christopher joined IOTA NanoSolutions Limited in March 2009 as Business Development Director. He is responsible for business development in the Pharmaceutical and Animal Health sectors. Immediately prior to joining IOTA NanoSolutions Christopher held the position of Pharmaceutical Business Unit Manager at IMCD UK Limited (the former bp Chemical subsidiary Honeywill & Stein Limited), a leading global distributor of specialty chemicals and functional ingredients. He also held other senior positions within IMCD including European Marketing Manager of the Group’s chemical synthesis business, European Product Manager of a portfolio of specialty chemicals, and General Manager of IMCD’s branch office in India. Christopher began his career within the Pharmaceuticals and Fine Chemicals division at Univar Limited, and over a period of more than 10 years has gained significant experience in the pharmaceutical, biotechnology and specialty chemicals sector, having held senior roles in international sales, marketing and purchasing. Christopher has a BSc (Hons) degree in Biological Sciences from the University of Sussex.